GlassScriptPhysician profile
Brian David Shaller
NPI 1962744672
$81,915.71
in general payments reported to CMS, 2019-2025
13 companies · $6,871 in 2025
The $6,871 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,163 · 2020: $352 · 2021: $1,019 · 2022: $721 · 2023: $32K · 2024: $38K · 2025: $6,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $15K · Education: $2,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,336.97 |
| Travel and Lodging | $14,864.20 |
| Education | $2,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $1,459.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $32,851.89 | 2024-2025 | Monarch Platform, Monarch |
| Ethicon INC. | $26,480.86 | 2021-2025 | Monarch Platform, Axert |
| Ambu INC. | $10,958.13 | 2022-2023 | |
| Intuitive Surgical, INC. | $2,877.82 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $2,500.00 | 2025 | |
| Covidien LP | $2,401.18 | 2019 | |
| Pulmonx Corporation | $1,204.47 | 2021-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Visionair Solutions, LLC | $1,137.50 | 2025 | Visionair Patient Specific Airway Stent |
| Boston Scientific Corporation | $996.12 | 2019-2020 | |
| Steris Corporation | $294.43 | 2024 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Noah Medical Corporation | $83.84 | 2025 | Galaxy |
| Astrazeneca Pharmaceuticals LP | $29.48 | 2024 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shaller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.